ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,921.30
0.76%
S&P ASX All Technology
3,078.20
0.32%
Brent Oil
79.745
0.00%
US Dollar vs AUD
1.52742
0.00%
Bitcoin
67,859.27
-0.08%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Atossa Therapeutics Inc (ATOS)

  7. Atossa Therapeutics Inc (ATOS) News

ATOS

Atossa Therapeutics (ATOS)

Atossa Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATOS
DateTimeSourceHeadlineSymbolCompany
22/07/202422:30GlobeNewswire Inc.Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast CancerNASDAQ:ATOSAtossa Therapeutics Inc
03/07/202406:15GlobeNewswire Inc.Atossa Therapeutics Appoints Heather Rees as Chief Financial OfficerNASDAQ:ATOSAtossa Therapeutics Inc
28/06/202422:30GlobeNewswire Inc.Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast CancerNASDAQ:ATOSAtossa Therapeutics Inc
17/06/202422:30GlobeNewswire Inc.Atossa Set to Join Russell 3000® Index Effective June 28, 2024NASDAQ:ATOSAtossa Therapeutics Inc
05/06/202422:30GlobeNewswire Inc.Atossa to Present at the Sidoti Small-Cap Investor ConferenceNASDAQ:ATOSAtossa Therapeutics Inc
28/05/202422:30GlobeNewswire Inc.Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment ModelNASDAQ:ATOSAtossa Therapeutics Inc
24/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ATOSAtossa Therapeutics Inc
23/05/202423:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ATOSAtossa Therapeutics Inc
15/05/202422:30GlobeNewswire Inc.Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical TrialNASDAQ:ATOSAtossa Therapeutics Inc
15/05/202406:46Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:ATOSAtossa Therapeutics Inc
14/05/202406:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ATOSAtossa Therapeutics Inc
13/05/202423:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ATOSAtossa Therapeutics Inc
13/05/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATOSAtossa Therapeutics Inc
13/05/202422:50GlobeNewswire Inc.Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:ATOSAtossa Therapeutics Inc
10/05/202423:04Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ATOSAtossa Therapeutics Inc
10/05/202423:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ATOSAtossa Therapeutics Inc
07/05/202422:30GlobeNewswire Inc.Atossa Therapeutics Announces Support of New Breast Cancer Screening GuidelinesNASDAQ:ATOSAtossa Therapeutics Inc
29/04/202422:30GlobeNewswire Inc.Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-EndoxifenNASDAQ:ATOSAtossa Therapeutics Inc
15/04/202422:30GlobeNewswire Inc.Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast CancerNASDAQ:ATOSAtossa Therapeutics Inc
11/04/202422:30GlobeNewswire Inc.Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare ConferenceNASDAQ:ATOSAtossa Therapeutics Inc
10/04/202401:59GlobeNewswire Inc.Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-EndoxifenNASDAQ:ATOSAtossa Therapeutics Inc
02/04/202407:00GlobeNewswire Inc.Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate UpdateNASDAQ:ATOSAtossa Therapeutics Inc
19/03/202423:30GlobeNewswire Inc.Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer PatientNASDAQ:ATOSAtossa Therapeutics Inc
18/03/202423:30GlobeNewswire Inc.Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing RequirementsNASDAQ:ATOSAtossa Therapeutics Inc
12/03/202423:30GlobeNewswire Inc.Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of DirectorsNASDAQ:ATOSAtossa Therapeutics Inc
23/02/202400:30GlobeNewswire Inc.Atossa Therapeutics Announces First Patient Dosing of (Z)-Endoxifen in the Ongoing RECAST DCIS StudyNASDAQ:ATOSAtossa Therapeutics Inc
08/02/202400:30GlobeNewswire Inc.Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical TrialNASDAQ:ATOSAtossa Therapeutics Inc
10/01/202400:30GlobeNewswire Inc.Atossa Therapeutics Issues Letter to ShareholdersNASDAQ:ATOSAtossa Therapeutics Inc
05/12/202300:30GlobeNewswire Inc.Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical DirectorNASDAQ:ATOSAtossa Therapeutics Inc
21/11/202300:30GlobeNewswire Inc.Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical TrialNASDAQ:ATOSAtossa Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ATOS

Your Recent History

PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
FX
AUDCAD
AUD vs CAD
FX
AUDUSD
AUD vs US Dollar
ASX
TLS
Telstra
ASX
WBC
Westpac Banking
ASX
CBA
Commonwealth Bank Of Aus...
FX
AUDJPY
AUD vs Yen
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
FX
GBPAUD
Sterling vs AUD
ASX
WPL
Woodside Petroleum
ASX
ORG
Origin Energy
ASX
XFL
S&P ASX 50
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved